Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma

BACKGROUND: The success of using glycolytic inhibitors for cancer treatment relies on better understanding the roles of each frequently deregulated glycolytic genes in cancer. This report analyzed the involvement of a key glycolytic enzyme, alpha-enolase (ENO1), in tumor progression and prognosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ye, Luo, Qisheng, Long, Hao, Hu, Zheng, Que, Tianshi, Zhang, Xi’an, Li, Zhiyong, Wang, Gang, Yi, Liu, Liu, Zhen, Fang, WeiYi, Qi, Songtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994408/
https://www.ncbi.nlm.nih.gov/pubmed/24650096
http://dx.doi.org/10.1186/1476-4598-13-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994408/
https://www.ncbi.nlm.nih.gov/pubmed/24650096
http://dx.doi.org/10.1186/1476-4598-13-65

Ejemplares similares